Donadio, M <br/><br/>
Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes.  [electronic resource] 

 -  Oncology  2005 
 - 408-13 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0030-2414 
<br/><br/><label>Standard No.: </label>10.1159/000089995  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anthracyclines--therapeutic use<br/>Antigen-Presenting Cells--cytology<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Capecitabine<br/>Cisplatin--administration & dosage<br/>Dendritic Cells--cytology<br/>Deoxycytidine--administration & dosage<br/>Disease Progression<br/>Enzyme-Linked Immunosorbent Assay<br/>Flow Cytometry<br/>Fluorouracil--analogs & derivatives<br/>Genes, Reporter<br/>Green Fluorescent Proteins--metabolism<br/>HLA-A Antigens--immunology<br/>HLA-A24 Antigen<br/>Humans<br/>Immunotherapy--methods<br/>Interferon-gamma--metabolism<br/>Leukocytes, Mononuclear--metabolism<br/>Microscopy, Fluorescence<br/>Neoplasm Metastasis<br/>RNA, Messenger--metabolism<br/>Remission Induction<br/>Taxoids--therapeutic use<br/>Time Factors<br/>Transcription, Genetic<br/>Treatment Outcome